Vaidya T, Nanivadekar A, Patel R. Imaging spectrum of abdominal manifestations of COVID-19. World J Radiol 2021; 13(6): 157-170 [PMID: 34249237 DOI: 10.4329/wjr.v13.i6.157]
Corresponding Author of This Article
Tanvi Vaidya, DNB, Attending Doctor, Department of Radiology, Ruby Hall Clinic, Sasoon Road, Pune 411001, Maharashtra, India. tanvivaidya5@gmail.com
Research Domain of This Article
Radiology, Nuclear Medicine & Medical Imaging
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Radiol. Jun 28, 2021; 13(6): 157-170 Published online Jun 28, 2021. doi: 10.4329/wjr.v13.i6.157
Imaging spectrum of abdominal manifestations of COVID-19
Tanvi Vaidya, Avinash Nanivadekar, Rajan Patel
Tanvi Vaidya, Avinash Nanivadekar, Rajan Patel, Department of Radiology, Ruby Hall Clinic, Pune 411001, Maharashtra, India
Author contributions: All authors have participated sufficiently in the drafting of this manuscript and take responsibility for the scientific content; Vaidya T and Nanivadekar A were involved in the study conceptualization; Vaidya T and Patel R took part in data acquisition; Patel R drafted the manuscript; Nanivadekar A designed the literature search and reviewed the manuscript; Nanivadekar A and Patel R performed final editing of the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tanvi Vaidya, DNB, Attending Doctor, Department of Radiology, Ruby Hall Clinic, Sasoon Road, Pune 411001, Maharashtra, India. tanvivaidya5@gmail.com
Received: February 3, 2021 Peer-review started: February 3, 2021 First decision: March 31, 2021 Revised: April 11, 2021 Accepted: May 24, 2021 Article in press: May 24, 2021 Published online: June 28, 2021 Processing time: 141 Days and 15.5 Hours
Abstract
Coronavirus disease 2019 (COVID-19) has posed a serious threat to global public health with its rapid spread, high fatality, and severe burden on health care providers all over the world. Although COVID-19 has been established as a respiratory tract infection, it can manifest with gastrointestinal symptoms as a consequence of direct infection by the virus or due to inflammation-mediated cytotoxicity. It has been observed that COVID-19 patients presenting with gastrointestinal symptoms tend to progress to a severe form of disease with increased morbidity and mortality, thus indicating the need for timely management. COVID-19 manifests with a wide spectrum of radiologic findings on gastrointestinal tract imaging, encompassing bowel abnormalities, hepato-biliary and pancreatic involvement, vascular occlusion, and solid organ infarction. Early recognition of these imaging features can facilitate timely treatment of COVID-19 associated gastrointestinal tract complications and may prompt the diagnosis of COVID-19 in patients with atypical disease manifestations. The aim of this article is to provide an overview of the various gastrointestinal imaging manifestations that can be encountered in patients with COVID-19, with an emphasis on early diagnosis of the disease as well as treatment related complications.
Core Tip: The gastrointestinal manifestations of coronavirus disease 2019 are being increasingly recognized. A variety of imaging features can be encountered, either due to direct infection by the virus or as a result of viral-mediated cytotoxicity and tissue damage. Imaging can play a key role in the early recognition of gastrointestinal tract involvement and its potentially fatal complications.
